Effect of nalbuphine in prevention of postspinal shivering after prosatate surgery.
Phase 3
- Conditions
- Health Condition 1: null- ASA grade 1 and 2
- Registration Number
- CTRI/2018/08/015223
- Lead Sponsor
- INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCESPATNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of ASA physical status ! and 2.
2.Patients between 20-60 years of age.
3.Patients able to comprehend and willing to participate.
4.Patient in whom nalbuphine is indicated for prevention of shivering.
Exclusion Criteria
1.Patients refusal to participate.
2.Contraindication to use of nalbuphine
3.Patient with known allergic to nalbuphine and bupivacaine.
4.Patient contraindicated to regional anaesthesia.
5.Obese patient with Body Mass Index (BMI >30).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of intrathecal nalbuphine on prevention of shivering after spinal anaesthesia in patients undergoing TURP.Timepoint: 0 min,10 min,20 min,30 min,40 min,50 min,60 min
- Secondary Outcome Measures
Name Time Method Effect of bupivacaine and nalbuphine on haemodynamics.Timepoint: 0 min,10 min,20 min,30 min,40 min,50 min,60min